Tudor Investment Corp’s Edwards Lifesciences EW Stock Holding History

Tudor Investment Corp’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-115,014	Closed	-$8.58M	–	3397
2025 Q1	$8.34M	Buy	+115,014	New	+$8.23M	0.03%	546
2024 Q4	–	Sell	-167,146	Closed	-$11.7M	–	3155
2024 Q3	$11M	Buy	+167,146	New	+$12.1M	0.04%	371
2024 Q1	–	Sell	-225,527	Closed	-$17.2M	–	2370
2023 Q4	$17.2M	Buy	+225,527	New	+$15.7M	0.14%	156
2023 Q3	–	Sell	-127,545	Closed	-$10.2M	–	2447
2023 Q2	$12M	Buy	+127,545	New	+$11.1M	0.14%	123
2023 Q1	–	Sell	-68,682	Closed	-$5.4M	–	2573
2022 Q4	$5.12M	Buy	68,682 +64,460	+1,527%	+$4.97M	0.1%	252
2022 Q3	$349K	Buy	+4,222	New	+$406K	0.01%	1679
2022 Q1	–	Sell	-37,937	Closed	-$4.26M	–	2204
2021 Q4	$4.92M	Buy	+37,937	New	+$4.43M	0.08%	268
2021 Q2	–	Sell	-44,600	Closed	-$3.73M	–	1686
2021 Q1	$3.73M	Buy	44,600 +29,453	+194%	+$2.49M	0.07%	270
2020 Q4	$1.38M	Buy	15,147 +7,438	+96%	+$617K	0.04%	566
2020 Q3	$615K	Sell	7,709 -12,953	-63%	-$1.01M	0.03%	732
2020 Q2	$1.43M	Buy	20,662 +11,578	+127%	+$823K	0.07%	356
2020 Q1	$571K	Sell	9,084 -147,891	-94%	-$10.7M	0.05%	435
2019 Q4	$12.2M	Buy	156,975 +143,469	+1,062%	+$11.2M	0.55%	14
2019 Q3	$990K	Buy	+13,506	New	+$949K	0.03%	500
2018 Q2	–	Sell	-58,575	Closed	-$2.72M	–	1095
2018 Q1	$2.72M	Sell	58,575 -89,535	-60%	-$3.89M	0.09%	113
2017 Q4	$5.56M	Buy	148,110 +68,829	+87%	+$2.53M	0.14%	25
2017 Q3	$2.89M	Buy	79,281 +50,538	+176%	+$1.93M	0.07%	157
2017 Q2	$1.13M	Sell	28,743 -596,730	-95%	-$21.8M	0.03%	304
2017 Q1	$19.6M	Buy	+625,473	New	+$19.6M	0.6%	32
2016 Q3	–	Sell	-50,058	Closed	-$1.66M	–	1516
2016 Q2	$1.66M	Buy	50,058 +42,258	+542%	+$1.45M	0.04%	272
2016 Q1	$229K	Sell	7,800 -21,741	-74%	-$600K	0.01%	1444
2015 Q4	$778K	Buy	29,541 +2,367	+9%	+$61.5K	0.02%	599
2015 Q3	$644K	Buy	27,174 +4,374	+19%	+$106K	0.02%	618
2015 Q2	$541K	Sell	22,800 -613,770	-96%	-$13.9M	0.02%	725
2015 Q1	$15.1M	Buy	636,570 +599,394	+1,612%	+$13.4M	0.48%	29
2014 Q4	$789K	Sell	37,176 -23,496	-39%	-$472K	0.03%	473
2014 Q3	$1.03M	Buy	60,672 +30,672	+102%	+$484K	0.04%	279
2014 Q2	$429K	Sell	30,000 -578,400	-95%	-$7.84M	0.02%	625
2014 Q1	$7.52M	Buy	+608,400	New	+$7.02M	0.32%	70
2013 Q4	–	Sell	-31,800	Closed	-$369K	–	1293
2013 Q3	$369K	Buy	+31,800	New	+$372K	0.02%	489

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Tudor Investment Corp's EW Position: Q2 2025 in Review

Tudor Investment Corp sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 115,014 shares — an estimated $8.58M sold.

Tudor Investment Corp first reported a position in EW in Q3 2013 and held it in 30 quarters. The position peaked at $19.6M in Q1 2017. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.

Tudor Investment Corp reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
Tudor Investment Corp sold 115,014 Edwards Lifesciences shares in Q2 2025, an estimated $8.58M.
Tudor Investment Corp first reported a position in Edwards Lifesciences in Q3 2013 and held it in 30 quarters.
Tudor Investment Corp's Edwards Lifesciences position peaked at $19.6M in Q1 2017.
1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.